SRPT Snapshot | |
---|---|
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts. | |
VALUATION DATA | |
Market Capitalization | $12,150,521,000 | Price to Sales | 4.00 |
Earnings per Share | $-5.7900 |
PE Ratio | None |
PRICE DATA | |
Most Recent Close | $129.4600 |
52 Week High | $9.77 |
52 Week Low | $14.22 |
50-Day Moving Average | $9.6 |
200-Day Moving Average | $-26.32 |
All data are from Alpha Vantage as of today. For more infomation on SRPT see Stock Dividend, Valuation, Price and Financial Data for Investors |